MOH — authorised 26 September 1989
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
MOH authorised Clozaril on 26 September 1989
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 26 September 1989.
NOVARTIS holds the Israeli marketing authorisation.